Home › Acceleron Highlights Phase 3 Studies, New Clinical Results And Research Strategies At Research And Development Day Event
 

Keywords :   


Acceleron Highlights Phase 3 Studies, New Clinical Results And Research Strategies At Research And Development Day Event

2015-11-03 04:51:04| drugdiscoveryonline Home Page

Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, recently announced the phase 3 clinical trial designs for the luspatercept program in myelodysplastic syndromes (“MEDALIST” study) and beta-thalassemia (“BELIEVE” study), phase 1 preliminary results from the ACE-083 program, and its new IntelliTrapdrug discovery platform

Tags: day results research development

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11Tropical Storm Sara Graphics
15.11Tropical Storm Sara Forecast Discussion Number 8
15.11Tropical Storm Sara Wind Speed Probabilities Number 8
15.11Tropical Storm Sara Public Advisory Number 8
15.11 20213 105S P7905-P
15.11 ()
15.11Mizuno Energy 25.5
15.11
More »